I Know First Review

The stocks selected here are the top performing stocks from I Know First Review: Daily Market Forecast’s February 21st 2017, stock forecast titled “Best Pharma Stocks Based on Deep Learning: Returns up to 77.42% in 14 Days”.

This forecast is part of the “Pharma Stocks” package, as one of I Know First’s quantitative investment solutions. The “I Know First Average” return was 14.72% over 14 days versus the S&P 500’s return of 2.34% over the same time period.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.

MDCO

Signal: 594.76

Predictability: 0.07

Return: 16.19%

Source: www.medicines.org.uk

The Medicines Company was founded in 1996 and is based in Parsippany, New Jersey. They provide medicines for patients in acute and intensive care hospitals worldwide. The company had a signal strength of 594.76 and a predictability indicator of 0.07. In accordance with the algorithm’s prediction, the stock price increased by 16.19%. Thus, the stock is increasing not because of the revenue or earnings, but the progression of Allnylam’s pipeline.

AGN

Signal: 118.27

Predictability: 0.32

Return: 7.14%

Allergan plc is a specialty pharmaceutical company that develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. AGN operates through US brands, US medical aesthetics, international brands and Anda Distribution segments. The company had a signal strength of 118.27 and a predictability indicator of 0.32. In accordance with the algorithm’s prediction, the stock price increased by 7.14%. Most of all,  the stock is increasing due to the Gold sponsorship of the Alzheimer’s Foundation of America’s “15th Anniversary National Educating America Tour.”

ALNY

Signal: 96.03

Predictability: 0.23

Return: 12.91%

Source: i.forbesimg.com

Alnylam Pharmaceuticals is a biopharmaceutical company that develops therapeutics based on RNA. Their research and development is primarily focused on N-acetylgalactosamine, or GalNAc-conjugate strategy for delivery of small interfering RNAs. Launching in 2002, the company is based in Cambridge. The company had a signal strength of 96.03 and a predictability indicator of 0.23. In accordance with the algorithm’s prediction, the stock price increased by 12.91%. Finally, the stock is increasing due to an added $350 million to its market cap.

TARO

Signal: 78.65

Predictability: 0.3

Return: 8.73%

Source: www.dealcurry.com

Taro Pharmaceutical Industries is a science-based pharmaceutical company, who develop, manufacture and market pharmaceutical products in many countries around the world. TARO allows consumers to purchase over the counter pharmaceutical products and prescriptions. Having been established in 1959, it’s based in Israel. The company had a signal strength of 78.65 and a predictability indicator of 0.3. In accordance with the algorithm’s prediction, the stock price increased by 8.73%. In conclusion, the return increased due to the company posting a revenue of $220.4 million.

ABC

Signal: 74.77

Predictability: 0.3

Return: 2.07%

AmerisourceBergen Corporation is a company that distributes pharmaceutical products internationally, distributing both branded and generic pharmaceuticals. They also provide management, staffing and consulting services. ABC was founded in 1985 and is based in Pennsylvania. The company had a signal strength of 74.77 and a predictability indicator of 0.3. In accordance with the algorithm’s prediction, the stock price increased by 2.07%. Consequently, the stock is increasing because of their plan to invest over $40 million in an “Amazon-like” warehouse.

VRX

Signal: 64.44

Predictability: 0.39

Return: 12.80%

Source: http://logosandbrands.directory

Valeant Pharmaceuticals International is a company that offers pharmaceuticals to consumers that can be purchased over-the-counter, as well as medical devices worldwide. It offers a wide variety of products and treatments for varying diseases. Previously, the company was known as Biovail Corporation before changing its name to Valeant Pharmaceuticals International Inc in September 2010. Having been founded in 1983, the company is based in Canada. The company had a signal strength of 64.44 and a predictability indicator of 0.39. In accordance with the algorithm’s prediction, the stock price increased by 12.80%. Hence, the rising stock is due to the company offloading some assets, bringing in major debt relief.

ABT 

Signal: 47.01

Predictability: 0.26

Return: 4.46%

Abbott Laboratories sells and produces health care products internationally. The company offers a wide range of established pharmaceutical products, for both branded and generic items. They provide nutritional products for both pediatrics and adults. Headquartered in Illinois, the company was founded in 1888. The company had a signal strength of 47.01 and a predictability indicator of 0.26. In accordance with the algorithm’s prediction, the stock price increased by 4.46%. Thus, the stock is rising owing to the fact of the acquisition of a $25 billion medical device maker St. Jude Medical.

Source: media.licdn.com

LGND

Signal: 45.47

Predictability: 0.12

Return: -1.72%

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company who focuses on establishing and acquiring technologies to help other companies overseas to discover medicines. They have commercial programs for various products and offers help for different infections. The company is based in California and was founded in 1987.

Source: www.annualreports.com

PPHM

Signal: 43.47

Predictability: 0.17

Return: 77.42%

Peregrine Pharmeceuticals, Inc is a company that researches and develops antibodies for cancer treatment in the U.S. The company also presents integrated manufacturing services for cell line development to commercial third-party customers. The company had a signal strength of 43.47 and a predictability indicator of 0.17. In accordance with the algorithm’s prediction, the stock price increased by 77.42%. As a result, the stock has increased due to a published positive proof-of-concept for a new exosome-based detection platform for cancer. The data can find a clear distinction between healthy individuals and patients that have ovarian tumours.

MYL

Signal: 42.65

Predictability: 0.23

Return: 7.24%

Mylan N.V., markets, develops and distributes both branded generic, generic and speciality pharmaceuticals worldwide. The products come in varying forms, whether it be capsule or tablet. The company had a signal strength of 42.65 and a predictability indicator of 0.23. In accordance with the algorithm’s prediction, the stock price increased by 7.24%. Therefore, the stock increased because in January 2017, the company had their licence application for biologics accepted.

Source: sportsperspectives.com